Camp4 Therapeutics Prices $30 Million Offering; Shares Fall Pre-Bell

MT Newswires Live
12/18

Camp4 Therapeutics (CAMP) said Thursday it has priced an underwritten offering of 5 million common shares at $6 per share for gross proceeds of $30 million.

The offering is set to close around Friday.

Net proceeds from the offering, along with existing cash, will be used to develop the company's product candidates, as well as for general corporate purposes.

Shares of Camp4 fell more than 6% in recent Thursday premarket activity.

Price: 6.70, Change: -0.43, Percent Change: -6.04

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10